JP Morgan Downgrades Surrozen to Underweight
JP Morgan analyst Eric Joseph downgrades Surrozen (NASDAQ:SRZN) from Neutral to Underweight.
Oppenheimer Downgrades CinCor Pharma to Perform
Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.
UBS Downgrades America Movil to Neutral, Raises Price Target to $22.5
UBS analyst Leonardo Olmos downgrades America Movil (NYSE:AMX) from Buy to Neutral and raises the price target from $20.4 to $22.5.
Why This Williams-Sonoma Analyst Has Turned Bearish On The Stock For 2023
Over the past three months, analysts have reduced their price targets for Williams-Sonoma, Inc. (NYSE: WSM) by around 30%.
What’s Going On With DraftKings Stock Today?
DraftKings Inc (NASDAQ: DKNG) shares are trading lower Monday following a downgrade from JPMorgan.
Morgan Stanley Downgrades Playtika Holding to Equal-Weight, Lowers Price Target to $12
Morgan Stanley analyst Matthew Cost downgrades Playtika Holding (NASDAQ:PLTK) from Overweight to Equal-Weight and lowers the price target from $20 to $12.
Morgan Stanley Downgrades AppLovin to Equal-Weight, Lowers Price Target to $20
Morgan Stanley analyst Matthew Cost downgrades AppLovin (NASDAQ:APP) from Overweight to Equal-Weight and lowers the price target from $35 to $20.
Stifel Downgrades Imago BioSciences to Hold, Raises Price Target to $36
Stifel analyst Stephen Willey downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $35 to $36.
Morgan Stanley Downgrades Aptiv to Equal-Weight, Lowers Price Target to $105
Morgan Stanley analyst Adam Jonas downgrades Aptiv (NYSE:APTV) from Overweight to Equal-Weight and lowers the price target from $120 to $105.
Jefferies Downgrades Twilio to Hold, Lowers Price Target to $50
Jefferies analyst Samad Samana downgrades Twilio (NYSE:TWLO) from Buy to Hold and lowers the price target from $110 to $50.